KAISER FAMILY FOUNDATION
-
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
Still, affordability remains a challenge. Adults with annual household incomes of $90,000 or greater were more likely than those with lower household incomes to say they have heard "a lot" about these drugs, the poll showed.
-
About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows
-
US kindergarten vaccination rate dropped again, data shows
-
CDC extends travel mask requirement to May 3 as COVID rises
-
Medicare Part D no match for runaway specialty drug costs -study
-
Headway on AIDS threatened by funding slowdown
Advertisement
Advertisement